Dr. Mitchell S. Cairo, MD
Pediatric Hematology & Oncology (Pediatric Hematology & Oncology Physician)
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Hematology & Oncology Physician primary
NY license 217898
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 9 companies reported 110 payments worth $147,997 in total to this clinician.
| Jazz Pharmaceuticals Inc. | $75,365 |
|---|---|
| Kite Pharma, Inc. | $34,982 |
| Amgen Inc. | $33,816 |
| Pfizer Inc. | $2,400 |
| Merck Sharp & Dohme LLC | $969 |
| Novartis Pharmaceuticals Corporation | $215 |
| Syndax Pharmaceuticals, Inc. | $135 |
| Mesoblast, Inc. | $99.49 |
| Compensation for services other than consulting (speaking, faculty) | $95,458 |
|---|---|
| Consulting Fee | $37,275 |
| Travel and Lodging | $12,964 |
| Food and Beverage | $2,300 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. May 14, 2025 | Compensation for services other than consulting (speaking, faculty) DEFITELIO · HEMATOLOGY/ONCOLOGY | $11,479 |
| Jazz Pharmaceuticals Inc. Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty) DEFITELIO · HEMATOLOGY/ONCOLOGY | $11,479 |
| Jazz Pharmaceuticals Inc. Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) RYLAZE · HEMATOLOGY/ONCOLOGY | $11,479 |
| Jazz Pharmaceuticals Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) RYLAZE · HEMATOLOGY/ONCOLOGY | $11,479 |
| Jazz Pharmaceuticals Inc. Sep 3, 2025 | Compensation for services other than consulting (speaking, faculty) RYLAZE · HEMATOLOGY/ONCOLOGY | $10,596 |
| Kite Pharma, Inc. Jan 7, 2025 | Consulting FeeCompany’s description;3857123;SAP;11260208 | $9,750 |
| Kite Pharma, Inc. Oct 1, 2025 | Consulting FeeCompany’s description;4143889;SAP;11260208 | $8,625 |
| Kite Pharma, Inc. Apr 8, 2025 | Consulting FeeCompany’s description;3952377;SAP;11260208 | $8,250 |
| Kite Pharma, Inc. Oct 14, 2025 | Consulting FeeCompany’s description;4157424;SAP;11260208 | $8,250 |
| Amgen Inc. Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $7,200 |
All 78 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Dec 19, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to Indianapolis, IN | $53.41 |
| Amgen Inc. Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $3,600 |
| Amgen Inc. Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $2,400 |
| Amgen Inc. Dec 9, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to Indianapolis, IN · in-kind | $677 |
| Amgen Inc. Dec 3, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to Indianapolis, IN · in-kind | $215 |
| Amgen Inc. Nov 26, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $3,600 |
| Amgen Inc. Nov 26, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $600 |
| Amgen Inc. Nov 26, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to New York, NY | $80.00 |
| Amgen Inc. Nov 26, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to New York, NY | $53.20 |
| Amgen Inc. Nov 26, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to New York, NY | $13.00 |
| Amgen Inc. Nov 16, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to Indianapolis, IN · in-kind | $468 |
| Amgen Inc. Oct 28, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $3,600 |
| Amgen Inc. Oct 28, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $600 |
| Kite Pharma, Inc. Oct 14, 2025 | Consulting FeeCompany’s description;4157424;SAP;11260208 | $8,250 |
| Amgen Inc. Oct 10, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to Hartford, CT · in-kind | $851 |
| Jazz Pharmaceuticals Inc. Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) RYLAZE · HEMATOLOGY/ONCOLOGY | $11,479 |
| Kite Pharma, Inc. Oct 1, 2025 | Consulting FeeCompany’s description;4143889;SAP;11260208 | $8,625 |
| Jazz Pharmaceuticals Inc. Oct 1, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to New Orleans, LA · in-kind | $428 |
| Jazz Pharmaceuticals Inc. Oct 1, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to New Orleans, LA · in-kind | $286 |
| Jazz Pharmaceuticals Inc. Oct 1, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to New Orleans, LA · in-kind | $86.40 |
| Jazz Pharmaceuticals Inc. Oct 1, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to New Orleans, LA · in-kind | $37.80 |
| Jazz Pharmaceuticals Inc. Oct 1, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to New Orleans, LA · in-kind | $13.00 |
| Jazz Pharmaceuticals Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) RYLAZE · HEMATOLOGY/ONCOLOGY | $11,479 |
| Jazz Pharmaceuticals Inc. Sep 25, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Indianapolis, IN · in-kind | $70.00 |
| Jazz Pharmaceuticals Inc. Sep 25, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Indianapolis, IN · in-kind | $56.00 |
| Jazz Pharmaceuticals Inc. Sep 25, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Indianapolis, IN · in-kind | $17.81 |
| Jazz Pharmaceuticals Inc. Sep 25, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Indianapolis, IN · in-kind | $13.00 |
| Jazz Pharmaceuticals Inc. Sep 12, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Indianapolis, IN · in-kind | $266 |
| Jazz Pharmaceuticals Inc. Sep 12, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Indianapolis, IN · in-kind | $266 |
| Jazz Pharmaceuticals Inc. Sep 11, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Indianapolis, IN · in-kind | $157 |
| Jazz Pharmaceuticals Inc. Sep 3, 2025 | Compensation for services other than consulting (speaking, faculty) RYLAZE · HEMATOLOGY/ONCOLOGY | $10,596 |
| Jazz Pharmaceuticals Inc. Sep 3, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $82.50 |
| Jazz Pharmaceuticals Inc. Sep 3, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $37.80 |
| Jazz Pharmaceuticals Inc. Sep 3, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $13.00 |
| Jazz Pharmaceuticals Inc. Aug 25, 2025 | Compensation for services other than consulting (speaking, faculty) RYLAZE · HEMATOLOGY/ONCOLOGY | $3,532 |
| Jazz Pharmaceuticals Inc. Aug 22, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $649 |
| Jazz Pharmaceuticals Inc. Aug 22, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $627 |
| Jazz Pharmaceuticals Inc. Aug 22, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $178 |
| Jazz Pharmaceuticals Inc. Aug 22, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $97.19 |
| Jazz Pharmaceuticals Inc. Aug 22, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $97.16 |
| Jazz Pharmaceuticals Inc. Aug 22, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $2.50 |
| Jazz Pharmaceuticals Inc. Aug 22, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $2.50 |
| Jazz Pharmaceuticals Inc. Aug 20, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Indianapolis, IN · in-kind | $289 |
| Amgen Inc. Jul 29, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to Richfield, OH · in-kind | $1,494 |
| Amgen Inc. Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $7,200 |
| Amgen Inc. Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $2,400 |
| Pfizer Inc. Jul 21, 2025 | Consulting Fee CIBINQO · Inflammation & Immunology | $2,400 |
| Amgen Inc. Jul 18, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to Richfield, OH · in-kind | $185 |
| Amgen Inc. Jul 11, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to Louisville, KY | $266 |
| Amgen Inc. Jul 11, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to Louisville, KY | $260 |
| Jazz Pharmaceuticals Inc. Jul 3, 2025 | Compensation for services other than consulting (speaking, faculty) RYLAZE · HEMATOLOGY/ONCOLOGY | $7,064 |
| Jazz Pharmaceuticals Inc. Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty) DEFITELIO · HEMATOLOGY/ONCOLOGY | $11,479 |
| Jazz Pharmaceuticals Inc. Jun 30, 2025 | Travel and Lodging DEFITELIO · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $62.97 |
| Jazz Pharmaceuticals Inc. Jun 30, 2025 | Travel and Lodging DEFITELIO · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $22.40 |
| Jazz Pharmaceuticals Inc. Jun 30, 2025 | Travel and Lodging DEFITELIO · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $10.00 |
| Jazz Pharmaceuticals Inc. Jun 26, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $190 |
| Jazz Pharmaceuticals Inc. Jun 26, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Detroit, MI · in-kind | $190 |
| Jazz Pharmaceuticals Inc. Jun 26, 2025 | Travel and Lodging DEFITELIO · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $153 |
| Jazz Pharmaceuticals Inc. Jun 26, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Columbus, OH · in-kind | $153 |
| Jazz Pharmaceuticals Inc. Jun 26, 2025 | Travel and Lodging DEFITELIO · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $2.70 |
| Jazz Pharmaceuticals Inc. Jun 26, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Columbus, OH · in-kind | $2.70 |
| Jazz Pharmaceuticals Inc. Jun 25, 2025 | Travel and Lodging DEFITELIO · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $179 |
| Amgen Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $3,600 |
| Jazz Pharmaceuticals Inc. Jun 24, 2025 | Travel and Lodging DEFITELIO · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $218 |
| Jazz Pharmaceuticals Inc. Jun 24, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Columbus, OH · in-kind | $218 |
| Amgen Inc. Jun 19, 2025 | Travel and Lodging BLINCYTO · Oncology · travel to Richfield, OH · in-kind | $464 |
| Jazz Pharmaceuticals Inc. Jun 7, 2025 | Travel and Lodging DEFITELIO · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $472 |
| Jazz Pharmaceuticals Inc. Jun 7, 2025 | Travel and Lodging RYLAZE · HEMATOLOGY/ONCOLOGY · travel to Columbus, OH · in-kind | $472 |
| Jazz Pharmaceuticals Inc. Jun 2, 2025 | Travel and Lodging DEFITELIO · HEMATOLOGY/ONCOLOGY · travel to Louisville, KY · in-kind | $565 |
| Jazz Pharmaceuticals Inc. Jun 2, 2025 | Travel and Lodging DEFITELIO · HEMATOLOGY/ONCOLOGY · travel to Louisville, KY · in-kind | $407 |
| Jazz Pharmaceuticals Inc. May 14, 2025 | Compensation for services other than consulting (speaking, faculty) DEFITELIO · HEMATOLOGY/ONCOLOGY | $11,479 |
| Merck Sharp & Dohme LLC Apr 9, 2025 | Travel and Lodging ONCOLOGY · travel to Dallas, TX Company’s descriptionProvided as part of a clinical research engagement. | $91.67 |
| Kite Pharma, Inc. Apr 8, 2025 | Consulting FeeCompany’s description;3952377;SAP;11260208 | $8,250 |
| Merck Sharp & Dohme LLC Mar 24, 2025 | Travel and Lodging ONCOLOGY · travel to Dallas, TX · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $353 |
| Merck Sharp & Dohme LLC Mar 24, 2025 | Travel and Lodging ONCOLOGY · travel to Dallas, TX · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $233 |
| Merck Sharp & Dohme LLC Mar 24, 2025 | Travel and Lodging ONCOLOGY · travel to Dallas, TX · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $116 |
| Amgen Inc. Feb 21, 2025 | Compensation for services other than consulting (speaking, faculty) BLINCYTO · Oncology | $750 |
| Kite Pharma, Inc. Jan 7, 2025 | Consulting FeeCompany’s description;3857123;SAP;11260208 | $9,750 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 9 industry-funded studies in 2025, from 6 companies. The companies reported $464,773 in research payments for these studies, mostly to the institutions running them.
- SPI-GCF-202
Spectrum Pharmaceuticals Inc. - Study name not reported
Servier Pharmaceuticals LLC - A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
E.r. Squibb & Sons, L.l.c. · Terminated · NCT05255601 - A Phase II Trial of Targeted Immunotherapy with Daratumumab Following Myeloablative Total Body Irradiation (TBI)-Based Conditioning and Allogeneic Hematopoietic Cell Transplantation in Children, Adolescents and Young …
Janssen Research & Development, LLC - A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
AbbVie Inc. · Active, not recruiting · NCT06508658 - ALLO-T-DART
Adaptive Biotechnologies Corporation - M20-429 - Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutane…
AbbVie Inc. - Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab
AbbVie Inc. · Active, not recruiting · NCT05206357 - A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adult Participants with Recurrent or Refractory Classical Hodgkin Lymphoma a…
E.r. Squibb & Sons, L.l.c.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.